Transcode Therapeutics (RNAZ) Return on Equity [ROE] (2021 - 2026)
Transcode Therapeutics' Return on Equity [ROE] was -730.92% in Q1 2026, down 139.34 percentage points from -591.58% a year earlier and down 103.84 percentage points from the prior quarter.
Powered by 
Analysis
Transcode Therapeutics (RNAZ) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Transcode Therapeutics came in at -828.09%.
- Return on Equity [ROE] shows a four-year change of -754.60 percentage points (FY2021 to FY2025).
- In earlier years, Return on Equity [ROE] was -797.67% in FY2023 (-639.96 pp), -157.71% in FY2022 (-84.22 pp) and -73.49% in FY2021.
- The Q1 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2024.
- Compared with a year earlier, Return on Equity [ROE] was higher in three of the last six quarters, with an average year-over-year change of +285.24 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 1600.13 percentage points); the worst was Q2 2023 (a drop of 2112.90 percentage points).
- Per Business Quant data, RNAZ's Return on Equity [ROE] in the three quarters before Q1 2026 was -627.09% (Q4 2025), -687.19% (Q3 2025) and -287.49% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Transcode Therapeutics | 1.37 Mn | -40.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -726.93% |
| Dec 31, 2025 | -627.09% |
| Sep 30, 2025 | -687.19% |
| Jun 30, 2025 | -287.49% |
| Mar 31, 2025 | -591.58% |
| Sep 30, 2024 | -988.93% |
| Jun 30, 2024 | -604.71% |
| Mar 31, 2024 | -574.17% |
| Dec 31, 2023 | -640.36% |
| Sep 30, 2023 | -638.06% |
| Jun 30, 2023 | -2,204.84% |
| Mar 31, 2023 | -1,333.78% |
| Dec 31, 2022 | -324.14% |
| Sep 30, 2022 | -155.89% |
| Jun 30, 2022 | -91.94% |
| Mar 31, 2022 | -32.36% |
| Dec 31, 2021 | -14.13% |
| Sep 30, 2021 | -5.79% |
API Access
Transcode Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNAZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RNAZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNAZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();